FLGT Gunggung Aset Perusahaan Fulgent Genetics Inc

Fulgent Genetics, Inc. (FLGT) ensures high scalability through DNA analysis automation and advanced IT software, which drastically reduces costs as order volumes grow. The business relies on oncology diagnostics and partnerships with US insurance companies. This price chart demonstrates total assets at 1144.91. Currently, the strategy focuses on integrating AI into big data processing and developing digital platforms for medical centers.

For Fulgent Genetics, Inc. (FLGT), total assets reflect the scale of infrastructure required to deploy IT platforms and integrate AI into sequencing. Analyzing the history of balance sheet assets, you can see the sum of equity and liabilities reverse-calculated via return on assets (ROA), which allows for an assessment of the efficiency of capital expenditures in high-tech R&D and spatial biology.